The Foreign Investment Promotion Board, chaired by Finance Secretary Rajiv Mehrishi, can recommend foreign investment proposals worth up to Rs 3,000 crore to the Finance Ministry for approval.
Of the 25 proposals on the agenda of the Board for June 15, four are related to pharmaceutical sector. These are Sudeep Pharma, Celon Laboratories, Shantha Biotechnics and Sparsha Pharma International.
Also Read
Investment applications of Sprint Telecom, Chorus Call, Cheetah Communications, Reliance Globalcom and Sistema Shyam Teleservices are also on the agenda.
FIPB had deferred decision on the application of Kotak Mahindra Bank in its earlier meeting. The private sector lender is seeking the Board's permission to raise foreign investment limit in the bank to 55 per cent.
India allows FDI in most of the sectors through automatic route, but in certain segments considered sensitive for the economy and security, the proposals have to be first cleared by FIPB.
During the 2014-15 fiscal, FDI grew 27 per cent year-on- year to USD 30.93 billion as against USD 24.29 billion in 2013-14, according to the data of Department of Industrial Policy and Promotion (DIPP).
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)